TipRanks
AIM ImmunoTech (DE:HXB)
FRANKFURT:HXB
Germany Market
HXB
AIM ImmunoTech
RESEARCH TOOLSreports

AIM ImmunoTech (HXB) Income Statement

1 Followers

AIM ImmunoTech Income Statement

Last quarter (Q2 2026), AIM ImmunoTech's total revenue was $26.00K, an increase of 4.00% from the same quarter last year. In Q2, AIM ImmunoTech's net income was $-3.79M. See AIM ImmunoTech’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 26Dec 24Mar 24Mar 23Mar 22
Total Revenue
$ 88.00K$ 170.00K$ 202.00K$ 141.00K$ 135.00K
Gross Profit
$ -250.00K$ 139.00K$ 160.00K$ 141.00K$ -715.00K
Operating Expenses
$ 10.28M$ 19.91M$ 32.08M$ 20.06M$ 18.12M
Depreciation and Amortization
$ 210.00K$ 246.00K$ 238.00K$ 256.00K$ 775.00K
EBITDA
$ -12.94M$ -16.49M$ -28.72M$ -19.19M$ -18.29M
Operating Income
$ -10.53M$ -19.77M$ -31.92M$ -19.92M$ -18.84M
Other Income/Expenses
$ -3.43M$ 2.45M$ 2.95M$ 477.81K$ -289.00K
Pretax Income
$ -13.96M$ -17.32M$ -28.96M$ -19.45M$ -19.13M
Net Income
$ -13.96M$ -17.32M$ -28.96M$ -19.45M$ -19.13M
Per Share Metrics
Basic EPS
$ -8.62$ -11.22$ -21.64$ -14.69$ -14.67
Diluted EPS
$ -8.62$ -11.22$ -21.64$ -14.69$ -14.67
Weighted Average Shares Outstanding
 1.62M 1.54M 1.34M 1.32M 1.30M
Weighted Average Shares Outstanding (Diluted)
 1.62M 1.54M 1.34M 1.32M 1.30M
Currency in USD

AIM ImmunoTech Earnings and Revenue History